Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
about
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsImaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Biomarkers in Alzheimer's disease.Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratoryNeurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaintsCerebrospinal fluid markers in Creutzfeldt-Jakob disease.Current state and future directions of neurochemical biomarkers for Alzheimer's disease.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer's diseaseCerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.Tau and p-tau as CSF biomarkers in dementia: a meta-analysis.Proteomic analysis of prion diseases: creating clarity or causing confusion?How many biomarkers to discriminate neurodegenerative dementia?Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer's disease.The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database.CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Biomarker identification for diagnosis of Alzheimer's disease.
P2860
Q26745508-9EEA2DE8-E310-463F-ACAC-66C4472A34F6Q26784569-929309B1-21D9-49B4-8211-EB2D5CFB5D81Q31108280-D6BAA94E-374A-41E6-A272-C812B3BAD128Q33590723-6B8262CA-0992-4D06-953F-A3A25A65D988Q35113795-7E71539B-6B2A-4E24-A752-E37D36733C60Q36216862-F0C5CB13-2037-4ACD-93F2-9B1C00311E3FQ36412490-74828DE6-E9C8-4BE8-A1B0-0CCF37164D8CQ36661066-87BD657B-D723-428A-B24C-71484E25B032Q36865663-6754279E-39FC-4074-BEAA-FA97C2DBEC1CQ36985933-83278D44-824C-44C4-BB20-B9C48BE9EBD4Q37068847-13D51661-B981-4C88-8357-500E01279A6DQ37118083-57825D08-0973-4957-88B7-BB9374052C65Q37165604-C9117B1B-6395-404D-93EE-F2F0533D3216Q37206262-AC8F2F30-E480-4F13-A632-79312EC72EE2Q37524486-FE3C0D2C-3170-4EDF-A965-2F52A7E692FCQ37697455-05A461B4-ECE3-41F4-966C-02167F0E3602Q37845820-D2578F0B-18DD-403B-B61D-FEED9CE8886CQ38060590-0470EFA9-9402-4F3C-9F35-E7ACC3887D9EQ38570242-DB86933E-C64F-4263-B84A-D6F11BD369D6Q38873321-186A87B7-02B2-435D-866B-79A4BFC913F6Q42656101-76D06043-5F4B-4E16-9E3E-FB968A106577Q48181665-5F60B86C-5316-48FB-A2A3-47C08F2492F8Q48913533-D3DCB617-5AB6-40C8-92B1-AEC8A6DF0CD6Q52589491-3E3AC875-81B6-49C8-AF1C-8B350CA2CE29Q53480286-4A3C7D23-7596-46E7-81B8-BAAF87EF69A9
P2860
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@en
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@nl
type
label
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@en
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@nl
prefLabel
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@en
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@nl
P2093
P50
P1476
Dissociation between CSF total ...... in Creutzfeldt-Jakob disease.
@en
P2093
Cheryl McCulloch
Daniel Kerkman
Hans Kretzschmar
Johannes Schröder
John DeBernardis
Katharina Buerger
Lukas Cepek
Markus Otto
Peter Schönknecht
Raymond Zinkowski
P356
10.1016/J.NEUROBIOLAGING.2004.12.003
P577
2006-01-01T00:00:00Z